Evidence map›Paper›PMID 30361911›Full record

ArticlePathology oncology research : POR2019

Expression of Programmed Death-Ligand 1 in Laryngeal Carcinoma and its Effects on Immune Cell Subgroup Infiltration.

Dan Yu, Jinzhang Cheng, Kai Xue, Xue Zhao, Lianji Wen, Chengbi Xu

Abstract read
PubMed Publisher
In one paragraph

Article in Pathology oncology research : POR, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 13 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Association betweenCancers · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Dan YuDepartment of Otolaryngology Head and Neck Surgery, The Second Hospital, Jilin University, No. 218 Ziqiang Street, Changchun, 130041, China.
Jinzhang ChengDepartment of Otolaryngology Head and Neck Surgery, The Second Hospital, Jilin University, No. 218 Ziqiang Street, Changchun, 130041, China.
Kai XueDepartment of Otolaryngology Head and Neck Surgery, The Second Hospital, Jilin University, No. 218 Ziqiang Street, Changchun, 130041, China.
Xue ZhaoDepartment of Otolaryngology Head and Neck Surgery, The Second Hospital, Jilin University, No. 218 Ziqiang Street, Changchun, 130041, China.
Lianji WenDepartment of Otolaryngology Head and Neck Surgery, The Second Hospital, Jilin University, No. 218 Ziqiang Street, Changchun, 130041, China.
Chengbi XuDepartment of Otolaryngology Head and Neck Surgery, The Second Hospital, Jilin University, No. 218 Ziqiang Street, Changchun, 130041, China. xuchengbi@163.com.
Jilin University · CN

Funding

International Cooperation Project from Science and Technology Department of Jilin Province 20180414054GHNational Natural Science Foundation of China 81572653National Natural Science Youth Foundation of China 81502348Natural Science Foundation of Jilin Province 20160101039JC
6 · The paper itself

Abstract

To study the expression of programmed death-ligand 1 (PD-L1), and its effects on CD8

Indexed as

B7-H1 AntigenCarcinoma, Squamous CellCD8-Positive T-LymphocytesFemaleFollow-Up StudiesHumansLaryngeal NeoplasmsLymphatic MetastasisLymphocytes, Tumor-InfiltratingMaleMiddle AgedTumor MicroenvironmentB7-H1 AntigenCD274 protein, humanImmunosuppressionLaryngeal squamous cell carcinomaPDL-1TAMs

Identifiers

PMID30361911
OpenAlexW2898436389

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.